Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula
Authors:
Open Access
- 1 May 1995
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 82 (5) , 638-641
Abstract
Somatostatin and octreotide both enhance closure of gastrointestinal fistulas. The present trial was undertaken to test whether early combined treatment with parenteral nutrition and octreotide 100 μg every 8 h by subcutaneous injection had a beneficial effect compared with parenteral nutrition plus placebo. Thirty‐one patients with postoperative gastrointestinal or pancreatic fistula were randomly assigned to receive parenteral nutrition plus octreotide (14 patients) or placebo (17) within 8 days of fistula onset. The percentage reduction in output and rate of spontaneous closure within 20 days were analysed. Mean(s.d.) reduction in output was similar after octreotide and placebo at 24 h (66(43) versus 68(47) per cent, P = 0.9), 48 h (60(46) versus 57(43) per cent, P = 0.8) and 72 h (62(50) versus 66(49) per cent, P = 0.9) after starting the combined treatment. Closure within 20 days was observed in eight of 14 fistulas in patients given octreotide and in six of 17 in those receiving placebo (P = 0.4). Administration of octreotide, within 8 days of fistula onset, associated with parenteral nutrition does not significantly increase the spontaneous fistula closure rate compared with parenteral nutrition plus placebo.Keywords
This publication has 14 references indexed in Scilit:
- Somatostatin in the Management of Gastrointestinal FistulasArchives of Surgery, 1992
- Effects of an antral mucosectomy, L-364,718 and atropine on cephalic phase of gastric and pancreatic secretion in dogsGastroenterology, 1990
- Treatment of pancreatic cutaneous fistulas with asomatostatin analogThe American Journal of Surgery, 1988
- Treatment of External Gastrointestinal Fistulas by a Combination of Total Parenteral Nutrition and SomatostatinJournal of Parenteral and Enteral Nutrition, 1987
- SOMATOSTATIN IN GASTROINTESTINAL FISTULAEThe Lancet, 1986
- Endocrine profile of a long-acting somatostatin derivative SMS 201–995. Study in normal volunteers following subcutaneous administrationEuropean Journal of Endocrinology, 1986
- Pharmacokinetics of SMS 201-995 in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- Clinical experience with fat-containing TPN solutions1983
- SOMATOSTATIN IN PERSISTENT GASTROINTESTINAL FISTULA TREATED BY TOTAL PARENTERAL NUTRITIONThe Lancet, 1982
- Growth Hormone Release Inhibiting Hormone in AcromegalyBMJ, 1974